Prostate cancer metastasis: Talking the walk

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1305-1306

  Coffey, Donald S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOSIN; THYMOSIN BETA15; TUMOR MARKER; UNCLASSIFIED DRUG;

CELL MOTILITY; HUMAN; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY;

ANIMALS; CELL MOVEMENT; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; THYMOSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029848240     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1305     Document Type: Short Survey

References (12)

1. Partin, A.W., Shoeniger, J.S., Mohler, J.L. & Coffey, D.S. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc. Natl. Acad. Sci. USA 86, 1254-1258 (1989).
2. Bao, L. et al. Thymosin β15: A novel regulator of cell tumor motility upregulated in metastatic prostate cancer. Nature Med. 2, 1322-1328 (1996).
3. Stossel, T.P. On the crawling of animal cells. Science 260,1086-1094 (1993).
4. Morton, R.A., Ewing, C.M., Nagafuchi, A., Tsukiata, S. & Isaacs, W.B. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res. 53, 3585-3590 (1993).
5. Umbas, R. et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancers. Cancer Res. 52, 5104-5109 (1992).
6. Ben-Ze'ev, A., Fernandez, J.L.R., Geiger, B., Zoller, M. & Gluck, U. Cytoskeletal plaque proteins as regulators of cell motility and tumor suppressors. in Cell Mechanics and Cellular Engineering (eds. Mow, V.C., Guilak, F., Tran-Son-Tay, R. & Hochmuth, R.M.) 273-293 (Springer-Verlag, New York, 1994).
7. Liotta, L.A. Cancer cell invasion and metastasis. Sci. Am. 266(Feb.), 54-63 (1992).
8. Liotta, L.A. et al. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA 83, 3302-3306 (1986).
9. Dong, J-T. et al. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884-888 (1995).
10. Mohler, J.L. et al. Detection of candidates for cancer cell motility inhibitor protein in the Dunning adenocarcinoma model. Clin. Exp. Metastasis 13, 774-780 (1995).
11. Dong, J-T. et al. Down-regulation of the KAI-1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56, 4387-4390 (1996).
12. Pienta, K.J. & Coffey, D.S. Cell motility as a chemotherapeutic target. Cancer Surv. 11, 255-263 (1993).